StonvexLoading…
StonvexStonvexStonvexCore line items from TRV's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $48.83B | $46.42B | $41.36B | $36.88B |
Operating Income | $7.80B | $6.18B | $3.37B | $3.35B |
Net Income | $6.29B | $5.00B | $2.99B | $2.84B |
EPS (Diluted) | $27.43 | $21.47 | $12.79 | $11.77 |
Total Assets | $143.71B | $133.19B | $125.98B | $115.72B |
Total Liabilities | $110.81B | $105.33B | $101.06B | $94.16B |
Cash & Equivalents | $842.00M | $699.00M | $650.00M | $799.00M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 217.50M | 226.60M | 228.20M | 232.10M |